SNT-2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of SNT-2, also known as SHC-transforming protein 2 or SH2 domain-containing transforming protein 2. SNT-2 is an adaptor protein that plays a critical role in various cellular signaling pathways, particularly those involved in growth factor signaling, cell differentiation, and survival. Adaptor proteins like SNT-2 do not have intrinsic enzymatic activity but instead function by mediating interactions between different signaling molecules, thereby facilitating the assembly of multiprotein complexes that transmit signals from cell surface receptors to intracellular targets. SNT-2 is characterized by its SH2 (Src Homology 2) domain, which allows it to bind to phosphorylated tyrosine residues on activated receptors or other signaling proteins, such as receptor tyrosine kinases (RTKs). This binding is crucial for the propagation of signals that regulate a variety of cellular processes, including cell growth, proliferation, and differentiation. By inhibiting SNT-2, researchers can disrupt these signaling pathways, providing a powerful tool to study the specific roles of SNT-2 in cellular signaling and function.
In research settings, SNT-2 inhibitors are valuable tools for exploring the molecular mechanisms by which SNT-2 facilitates signal transduction and the broader implications of its activity on cellular behavior. By blocking SNT-2 activity, scientists can investigate how inhibition affects the assembly and stability of signaling complexes, particularly focusing on the impact on downstream signaling cascades, such as the MAPK/ERK pathway, which is critical for cell proliferation and survival. This inhibition allows researchers to study the downstream effects on cellular processes such as growth regulation, differentiation, and apoptosis, where SNT-2-mediated signaling plays a pivotal role. Additionally, SNT-2 inhibitors provide insights into the interactions between SNT-2 and other signaling proteins, shedding light on the complex networks that regulate cellular responses to external stimuli. Through these studies, the use of SNT-2 inhibitors enhances our understanding of the critical role of adaptor proteins in signal transduction, the regulation of intracellular signaling pathways, and the broader implications of these processes for cellular homeostasis and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
This calcium chelator may sequester intracellular calcium, potentially leading to the downregulation of SNT-2 expression, which relies on calcium for its function. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
This inhibitor of the IP3 receptor might deplete intracellular calcium stores, leading to the downregulation of calcium-dependent SNT-2 expression in neuronal cells. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
As a SERCA pump inhibitor, thapsigargin may lead to the depletion of calcium from the endoplasmic reticulum, potentially causing a decrease in SNT-2 expression due to altered calcium homeostasis. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
By blocking store-operated calcium entry, 2-APB may reduce the intracellular calcium level, which could lead to the downregulation of SNT-2 in nerve cells. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
This compound's ability to inhibit receptor-mediated calcium entry might decrease SNT-2 expression by reducing the availability of calcium required for its synaptic functions. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil could inhibit voltage-gated calcium channels, potentially leading to decreased SNT-2 expression by reducing calcium influx necessary for its activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
By blocking L-type calcium channels, nifedipine may reduce calcium entry, which could lead to a reduction in the expression of SNT-2 involved in neurotransmitter release. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride may disrupt intracellular signaling pathways, such as GSK-3 inhibition, potentially resulting in the downregulation of genes like SNT-2 involved in synaptic plasticity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
By inhibiting the GTPase activity required for vesicle scission, Dynasore could decrease the proper formation and function of synaptic vesicles, thereby potentially reducing SNT-2 expression. | ||||||
Tetrandrine | 518-34-3 | sc-201492 sc-201492A | 100 mg 250 mg | $56.00 $100.00 | 9 | |
This compound may block ion channels that are essential for maintaining ionic balances that govern neurotransmitter release, potentially resulting in decreased SNT-2 expression. | ||||||